Home Newsletters Hematopoiesis News Lipase-Triggered Drug Release from BCL2 Inhibitor ABT-199-Loaded Nanoparticles to Elevate Anti-leukemic Activity...

Lipase-Triggered Drug Release from BCL2 Inhibitor ABT-199-Loaded Nanoparticles to Elevate Anti-leukemic Activity through Enhanced Drug Targeting on the Mitochondrial Membrane

By
Justin.choi
-
0
Researchers compared the anti-leukemic ability of pure ABT-199 and PEG-ABT-199 in vitro and in vivo.
[Acta Biomaterialia]
6445212 BBBBBBBB items 1 apa 0 default asc 1 173899 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
AbstractGraphical Abstract

RELATED ARTICLES

Exit mobile version